IN191024B - - Google Patents

Info

Publication number
IN191024B
IN191024B IN922MU2001A IN191024B IN 191024 B IN191024 B IN 191024B IN 922MU2001 A IN922MU2001 A IN 922MU2001A IN 191024 B IN191024 B IN 191024B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Mehta Bharat Pravinchandra
Doshi Madhukant Dr Mansukhlal
Joshi Milind Dr Dattatraya
Original Assignee
J B Chemicals And Pharmaceutic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J B Chemicals And Pharmaceutic filed Critical J B Chemicals And Pharmaceutic
Priority to IN922MU2001 priority Critical patent/IN191024B/en
Priority to US09/992,897 priority patent/US20030064101A1/en
Priority to RU2001132479/14A priority patent/RU2214820C2/ru
Publication of IN191024B publication Critical patent/IN191024B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
IN922MU2001 2001-09-25 2001-09-25 IN191024B (en:Method)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN922MU2001 IN191024B (en:Method) 2001-09-25 2001-09-25
US09/992,897 US20030064101A1 (en) 2001-09-25 2001-11-06 Floating osmotic device for controlled release drug delivery
RU2001132479/14A RU2214820C2 (ru) 2001-09-25 2001-11-30 Таблетированная фармацевтическая композиция

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN922MU2001 IN191024B (en:Method) 2001-09-25 2001-09-25

Publications (1)

Publication Number Publication Date
IN191024B true IN191024B (en:Method) 2003-09-13

Family

ID=11097296

Family Applications (1)

Application Number Title Priority Date Filing Date
IN922MU2001 IN191024B (en:Method) 2001-09-25 2001-09-25

Country Status (3)

Country Link
US (1) US20030064101A1 (en:Method)
IN (1) IN191024B (en:Method)
RU (1) RU2214820C2 (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN104825397A (zh) * 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
JP5349290B2 (ja) * 2006-04-03 2013-11-20 オディディ,イサ 薬物送達組成物およびそれを含む医薬品、ならびにその製造方法
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
DE102007026037A1 (de) * 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
CN101856339A (zh) * 2009-04-09 2010-10-13 广州柏赛罗药业有限公司 一种控释制剂及其制备方法
DE102011051653A1 (de) * 2011-07-07 2013-01-10 Lts Lohmann Therapie-Systeme Ag Quellfähige Manteltablette
WO2013077825A1 (en) * 2011-11-23 2013-05-30 Mahmut Bilgic Preparation process for a formulation comprising metformin
RU2677649C2 (ru) * 2013-02-21 2019-01-18 Глэнмарк Фармасьютикалс Лимитед Фармацевтические композиции монтелукаста и левоцетиризина
EP3551173A1 (en) 2016-12-09 2019-10-16 Bayer Animal Health GmbH Pharmaceutical preparation and method for its manufacture
EP3628004B1 (en) * 2018-06-27 2021-09-22 Amneal Complex Products Research LLC Self-regulating osmotic gastroretentive drug delivery systems
US20220241184A1 (en) * 2019-06-21 2022-08-04 Kashiv Biosciences, Llc Gastroretentive dosage forms of levodopa and carbidopa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776493A (en) * 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
RU2097026C1 (ru) * 1996-03-05 1997-11-27 Закрытое акционерное общество "Пульмомед" Лекарственное средство для предупреждения и купирования приступов бронхиальной астмы и лекарственная форма

Also Published As

Publication number Publication date
US20030064101A1 (en) 2003-04-03
RU2214820C2 (ru) 2003-10-27

Similar Documents

Publication Publication Date Title
BE2022C531I2 (en:Method)
BE2022C502I2 (en:Method)
BE2022C547I2 (en:Method)
BE2017C059I2 (en:Method)
BE2017C055I2 (en:Method)
BE2017C032I2 (en:Method)
BE2016C051I2 (en:Method)
BE2015C046I2 (en:Method)
BE2014C052I2 (en:Method)
BE2014C036I2 (en:Method)
BE2014C026I2 (en:Method)
BE2017C050I2 (en:Method)
BRPI0204884A2 (en:Method)
BE2016C021I2 (en:Method)
JP2002195220A5 (en:Method)
JP2002094398A5 (en:Method)
JP2001242811A5 (en:Method)
IN191024B (en:Method)
ECSDI045123S (en:Method)
BRPI0210463A2 (en:Method)
JP2002105773A5 (en:Method)
JP2002232420A5 (en:Method)
JP2002057909A5 (en:Method)
JP2002238044A5 (en:Method)
JP2002247343A5 (en:Method)